Visualitzant CEMCAT - Articles científics per títol
Ara mostrant els elements 29-48 d 106
-
Deciphering Multiple Sclerosis Progression
(Frontiers Media, 2021-04) -
Diagnostic challenge in children with an acquired demyelinating syndrome: an illustrative case report
(Frontiers Media, 2023-07-20) -
Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging
(Lippincott, Williams & Wilkins, 2023-01-17) -
Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community
(SAGE Publications, 2023-10) -
Early Reduction of MRI Activity During 6 Months of Treatment With Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis
(Lippincott Williams & Wilkins, 2022-07) -
Effect of Evobrutinib on Slowly Expanding Lesion Volume in Relapsing Multiple Sclerosis: A Post Hoc Analysis of a Phase 2 Trial
(Wolters Kluwer Health, 2024-03-12) -
Effect of Ozanimod on Symbol Digit Modalities Test Performance in Relapsing MS
(Elsevier, 2021-02) -
Expert-Agreed Practical Recommendations on the Use of Cladribine
(Springer, 2022-12) -
Genetic influences on disease course and severity, 30 years after a clinically isolated syndrome
(Oxford University Press, 2023) -
Genetic variation in NDFIP1 modifies the metabolic patterns in immune cells of multiple sclerosis patients
(Nature Research, 2021-11-01) -
Immunomodulatory Effects Associated with Cladribine Treatment
(MDPI, 2021-12)